Most systematic review s and meta-analyses from controlled feeding trials have shown that fructose-containing sugars in isocaloric exchange for other carbohydrates do not show evidence of harm and , in the case of fructose , may even have advantages for glycaemic control , especially at small doses .
Nevertheless , trials in which fructose-containing sugars supplement diets with excess energy have shown adverse effects , effects that appear more attributable to the excess energy than the sugar .
There is no unequivocal evidence that fructose intake at moderate doses is directly related with adverse metabolic effects , although there is potentially cause for concern where fructose is provided at high doses or contributes excess energy to diets .
Concerns are growing regarding the role of dietary sugars in the development of obesity and cardiometabolic diseases , including diabetes .
High-fructose corn syrup ( HFCS ) and sucrose are the most important dietary sweeteners .
Both HFCS and sucrose have overlapping metabolic actions with adverse effects attributed to their fructose moiety .
Ecological studies have linked the rise in fructose availability with the increases in obesity and diabetes worldwide .
This link has been largely underpinned by animal models and select human trials of fructose overfeeding at high levels of exposure .
Graded sucrose/carbohydrate diets in overtly hypertriglyceridemic diabetic patients.
Overtly hypertriglyceridemic patients with non-insulin-dependent diabetes mellitus were given a control diet containing 120 g of sucrose and 50 percent carbohydrate , and later r and omly assigned to receive isocaloric high- ( 220 g ) , intermediate- ( 120 g ) , or low- ( less than 3 g ) sucrose/carbohydrate diets for four weeks . The low-sucrose diet group demonstrated a modest but significant decrease in mean fasting serum glucose level in the first week only , although this change was no different from the other two dietary groups and was not sustained . All groups had little change in late postpr and ial serum glucose levels from control values , and no significant alterations in 24-hour glycosuria . The high-sucrose diet group demonstrated a significant increase in fasting serum triglyceride levels by the second week of the study , whereas the intermediate- and low-sucrose diet groups showed a decrease in mean fasting triglyceride levels . In contrast , the low-sucrose diet group 's late postpr and ial serum triglyceride levels increased by the fourth week , whereas levels fell in the high-sucrose diet group . Mean fasting serum cholesterol concentrations decreased from control values in the high-sucrose diet group . Thus , although very high sucrose and carbohydrate consumption is clearly deleterious to fasting tryglyceride levels in non-insulin-dependent diabetes mellitus with preexisting hypertriglyceridemia , it appears that low dietary sucrose and carbohydrate proportions do not further improve prepr and ial glycemia and glycosuria and may adversely affect late postpr and ial serum triglyceride concentration . This study suggests that isocaloric sucrose and carbohydrate restriction below usual daily levels ( 120 g per day ) offers no consistent benefit in glycemia or lipid control in overt type II diabetes
Most systematic review s and meta-analyses from controlled feeding trials have shown that fructose-containing sugars in isocaloric exchange for other carbohydrates do not show evidence of harm and , in the case of fructose , may even have advantages for glycaemic control , especially at small doses .
Nevertheless , trials in which fructose-containing sugars supplement diets with excess energy have shown adverse effects , effects that appear more attributable to the excess energy than the sugar .
There is no unequivocal evidence that fructose intake at moderate doses is directly related with adverse metabolic effects , although there is potentially cause for concern where fructose is provided at high doses or contributes excess energy to diets .
Concerns are growing regarding the role of dietary sugars in the development of obesity and cardiometabolic diseases , including diabetes .
High-fructose corn syrup ( HFCS ) and sucrose are the most important dietary sweeteners .
Both HFCS and sucrose have overlapping metabolic actions with adverse effects attributed to their fructose moiety .
Ecological studies have linked the rise in fructose availability with the increases in obesity and diabetes worldwide .
This link has been largely underpinned by animal models and select human trials of fructose overfeeding at high levels of exposure .